Climb Bio (CLYM) Other Working Capital Changes (2022 - 2026)
Climb Bio (CLYM) posted Other Working Capital Changes of -$62000.0 for Q1 2026, up 70.05% on a QoQ basis from -$207000.0 in Q4 2025, and down 5.08% year-over-year from -$65321.4 in Q1 2025.
Climb Bio (CLYM) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Climb Bio's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$62000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 5.08% year-over-year to -$62000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$210000.0 (up 19.85% YoY) and the FY2025 annual result came in at -$207000.0, up 36.7% from the prior year.
- Other Working Capital Changes was -$62000.0 for Q1 2026 at Climb Bio, up from -$207000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $102000.0 in Q2 2024 and bottomed at -$269000.0 in Q3 2024.
- A 5-year average of -$92937.5 and a median of -$104500.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 200.0% — and 2025, when it tumbled 475.0%.
- Climb Bio's Other Working Capital Changes stood at -$91000.0 in 2022, then declined by 20.88% to -$110000.0 in 2023, then jumped by 67.27% to -$36000.0 in 2024, then tumbled by 475.0% to -$207000.0 in 2025, then jumped by 70.05% to -$62000.0 in 2026.
- Business Quant data shows CLYM's Other Working Capital Changes at -$62000.0 in Q1 2026, -$207000.0 in Q4 2025, and $59000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,000.00 |
| Mar 31, 2026 | -62,000.00 |
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | -207,000.00 |
| Dec 31, 2025 | -207,000.00 |
| Dec 31, 2025 | -207,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Mar 31, 2025 | -59,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Dec 31, 2024 | -36,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 102,000.00 |